Menu
Currency
GWAS Study

Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.

Klarin D, Damrauer SM, Cho K et al.

30275531 PubMed ID
GWAS Study Type
617303 Participants
89 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KD
Klarin D
DS
Damrauer SM
CK
Cho K
SY
Sun YV
TT
Teslovich TM
HJ
Honerlaw J
GD
Gagnon DR
DS
DuVall SL
LJ
Li J
PG
Peloso GM
CM
Chaffin M
SA
Small AM
HJ
Huang J
TH
Tang H
LJ
Lynch JA
HY
Ho YL
LD
Liu DJ
EC
Emdin CA
LA
Li AH
HJ
Huffman JE
LJ
Lee JS
NP
Natarajan P
CR
Chowdhury R
SD
Saleheen D
VM
Vujkovic M
BA
Baras A
PS
Pyarajan S
DA
Di Angelantonio E
NB
Neale BM
NA
Naheed A
KA
Khera AV
DJ
Danesh J
CK
Chang KM
AG
Abecasis G
WC
Willer C
DF
Dewey FE
CD
Carey DJ
CJ
Concato J
GJ
Gaziano JM
OC
O'Donnell CJ
TP
Tsao PS
KS
Kathiresan S
RD
Rader DJ
WP
Wilson PWF
AT
Assimes TL
Chapter II

Abstract

Summary of the research findings

The Million Veteran Program (MVP) was established in 2011 as a national research initiative to determine how genetic variation influences the health of US military veterans. Here we genotyped 312,571 MVP participants using a custom biobank array and linked the genetic data to laboratory and clinical phenotypes extracted from electronic health records covering a median of 10.0 years of follow-up. Among 297,626 veterans with at least one blood lipid measurement, including 57,332 black and 24,743 Hispanic participants, we tested up to around 32 million variants for association with lipid levels and identified 118 novel genome-wide significant loci after meta-analysis with data from the Global Lipids Genetics Consortium (total n > 600,000). Through a focus on mutations predicted to result in a loss of gene function and a phenome-wide association study, we propose novel indications for pharmaceutical inhibitors targeting PCSK9 (abdominal aortic aneurysm), ANGPTL4 (type 2 diabetes) and PDE3B (triglycerides and coronary disease).

215,551 European ancestry individuals, 57,332 African American individuals, 24,743 Hispanic individuals

Chapter III

Study Statistics

Key metrics and study information

617303
Total Participants
GWAS
Study Type
Yes
Replicated
Up to 319,677 individuals
Replication Participants
African American or Afro-Caribbean, European, Hispanic or Latin American
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.